Sania Therapeutics is developing safe and effective gene therapies for the nervous system
Sania Therapeutics has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in March 2022.
Sania Therapeutics is headquartered in London, United Kingdom.
Sania Therapeutics is developing safe and effective gene therapies for the nervous system
Sania Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sania Therapeutics — Funding & Investors." VCBacked, March 23, 2022, https://www.vcbacked.co/company/sania-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). Sania Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/sania-therapeutics
{{cite web |title=Sania Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sania-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated